Middle East and Africa Contrast and Imaging Agents in Interventional X-ray Market Industry Trends Forecast to 2026
Short Description
By Agent Type (Iodinated Contrast Media, Barium-Based Contrast Media, Microbubble Contrast Media, Gold Nanoparticle Contrast Agents, Others), Application (Cardiology, Gastroenterology, Neurology, Oncology, Urology, General Surgery), End User (Imaging Centers, Hospital, Clinics, Diagnostic Center, Ambulatory Surgical Centers, Private Practices), Country (South Africa and rest of Middle East and Africa)
Market Definition
Contrast and imaging agents in interventional X-ray market plays an important role in improving the health-related issues in the healthcare sector. Contrast material, which is also known as contrast agents or contrast media, is used to improve image quality of the inside of the body produced by X-rays, computed tomography (CT) and other imaging techniques. By using contrast materials radiologists can distinguish normal from abnormal conditions within the body.
Contrast agents or media doesn’t permanently discolor internal organs. Prior to the imaging exam, when the contrast agent is introduced in the body, these contrast materials forms some shape in the body which helps to appear different than that if no contrast agent is administered. Contrast agents or media help physicians diagnose medical conditions by improving the vision. The material is absorbed by the body or eliminated through urine or bowel movements. There are various ways to use contrast material such as swallowed (taken by mouth or orally), injected into a blood vessel (vein or artery; also called given intravenously or intra-arterially) and administered by enema (given rectally).
Different types of contrast materials are available including Iodine-based and barium-sulphate compounds used majorly in X ray and CT, Gadolinium which is used in magnetic resonance (MR) imaging and many others.
Market Segmentation
Middle East and Africa contrast and imaging agents in interventional X-ray market is categorized into three segments which are agent type, application and end user.
On the basis of agent type, the market is segmented into iodinated contrast media, barium-based contrast media, microbubble contrast media, gold nanoparticle contrast agents and others.
On the basis of application, the market is segmented into cardiology, gastroenterology, neurology, oncology, urology and general Surgery. The cardiology segment is further sub segmented into percutaneous coronary intervention, structural heart disease, congenital heart disease and electrophysiology.
On the basis of end user, the market is segmented into imaging centers, hospital, clinics, diagnostic center, ambulatory surgical centers and private practices.
Market Players
The key market players for Middle East and Africa contrast and imaging agents in interventional X-ray market are listed below:
• General Electric Company
• BRACCO
• Guerbet
• Lantheus Medical Imaging, Inc.
• FUJIFILM VisualSonics Inc.
• Jodas Expoim
• TAEJOON PHARM
• Unijules Life Sciences Ltd.
• J.B.Chemicals & Pharmaceuticals Ltd.
• iMAX
• Novalek Pharmaceuticals Pvt. Ltd.
• Nano Therapeutics Pvt Ltd
• Others
The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Middle East & Africa contrast and imaging agents in interventional X-ray market is projected to register a healthy CAGR of 4.2% in the forecast period 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026. Market Segmentation By Agent Type (Iodinated Contrast Media, Barium-Based Contrast Media, Microbubble Contrast Media, Gold Nanoparticle Contrast Agents, Others), Application (Cardiology, Gastroenterology, Neurology, Oncology, Urology, General Surgery), End User (Imaging Centers, Hospital, Clinics, Diagnostic Center, Ambulatory Surgical Centers, Private Practices), Country (South Africa and rest of Middle East and Africa) Major growing sectors under the market segmentation are as follows: • In agent type, iodinated contrast media is dominating as well as the fastest growing segment in this market. • In application, cardiology is dominating as well as the fastest growing segment in the market. • In end user, imaging centers is dominating as well as the fastest growing segment in the market. Market Players The key market players for Middle East & Africa contrast and imaging agents in interventional X-ray market are listed below: • General Electric Company • BRACCO • Guerbet • Lantheus Medical Imaging, Inc. • FUJIFILM VisualSonics Inc. • Jodas Expoim • TAEJOON PHARM • Unijules Life Sciences Ltd. • J.B.Chemicals & Pharmaceuticals Ltd. • iMAX • Novalek Pharmaceuticals Pvt. Ltd. • Nano Therapeutics Pvt Ltd • Others
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook